Developmental Activities:

Non-Human Clinical Studies

  • cGMP fill and finish operations for pre-filled syringes and auto-injector systems
  • Chemistry and Manufacturing Control (CMC) sections of a Drug Application
  • Identification and qualification of suppliers of device components and assemblies
  • drug solution excipients and active pharmaceutical ingredients (API)
  • Formulation development
  • Container closure system manufacturers in the selection of drug contact materials
  • ICH shelf-life studies
  • Assay method and specifications for API, excipients and final drug product
  • Identification of drug impurities
  • Toxicology studies per FDA Guidelines

MSA News

NIH SBIR Grant application 1/5/2022

Mesa Science Associates has applied for an NIH Small Business Innovative Research (SBIR) Grant from the National Institutes of Health…

Read More

Mesa Green Caine Study Results Reported at Epilepsy Conference

Mesa Science Associates Inc. (MSA) and Mesa Green Pharma LLC (MGP) are pleased to announce the results of a study…

Read More

Mesa Green Pharma LLC Receives Positive Feedback from FDA’s Center for Veterinary Medicine

Pilot Study Provides Positive Results for K9MGP Treatment Active Canine Seizures FREDERICK, Md. September 21,2021— Mr. Michael Mesa, CEO of…

Read More